Pravin Dugel - Jan 2, 2023 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
President, Director
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Pravin U. Dugel
Stock symbol
ISEE
Transactions as of
Jan 2, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 05:35 PM
Previous filing
Dec 22, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +12.5K +9.18% $0.00 149K Jan 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -12.5K -25% $0.00 37.5K Jan 2, 2023 Common Stock 12.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units.
F2 On December 16, 2021, the Reporting Person was granted 50,000 restricted stock units, which vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026), subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.